A prospective study of 68Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential 177Lu-PSMA therapy

被引：0
|
作者：
Shamim Ahmed Shamim
Naresh Kumar
Geetanjali Arora
Sahil Jaswal
Shivanand Shalimar
Chandrasekhar Gamanagatti
机构：
[1] All India Institute of Medical Sciences (AIIMS),Department of Nuclear Medicine
[2] AIIMS,Department of Gastroenterology and Human Nutrition
[3] AIIMS,Department of Radiodiagnosis
来源：
Annals of Nuclear Medicine | 2024年 / 38卷
关键词：
Hepatocellular carcinoma (HCC); PSMA; SUV; Ga-PSMA PET/CT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：103 / 111
页数：8
相关论文
共 50 条
  • [21] 68Ga-PSMA PET/CT Imaging in Metastatic Medullary Thyroid Cancer: Preliminary Results of a Prospective Study
    Sahin, K.
    Sager, M. S.
    Kibar, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S512 - S513
  • [22] 68Ga-PSMA PET imaging of adenoid cystic carcinoma
    Nulent, T. J. W. Klein
    Willems, S. M.
    de Roos, R.
    Krijger, G. C.
    Ververs, F. F. T.
    van Es, R. J.
    de Keizer, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S437 - S437
  • [23] Extension of a 68Ga-PSMA PET-based nomogram for outcome prediction of 177Lu-PSMA radioligand therapy for the use of 18F-rhPSMA-7.3
    Rauscher, I.
    Hansen, K.
    Gafita, A.
    Weber, W. A.
    Eiber, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S327 - S327
  • [24] Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
    Bernhard Grubmüller
    Daniela Senn
    Gero Kramer
    Pascal Baltzer
    David D’Andrea
    Karl Hermann Grubmüller
    Markus Mitterhauser
    Harald Eidherr
    Alexander R. Haug
    Wolfgang Wadsak
    Sarah Pfaff
    Shahrokh F. Shariat
    Marcus Hacker
    Markus Hartenbach
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1063 - 1072
  • [25] Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
    Grubmueller, Bernhard
    Senn, Daniela
    Kramer, Gero
    Baltzer, Pascal
    D'Andrea, David
    Grubmueller, Karl Hermann
    Mitterhauser, Markus
    Eidherr, Harald
    Haug, Alexander R.
    Wadsak, Wolfgang
    Pfaff, Sarah
    Shariat, Shahrokh F.
    Hacker, Marcus
    Hartenbach, Markus
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (05) : 1063 - 1072
  • [26] Parathyroid Adenoma Detected in 68Ga-PSMA PET/CT but Not in the Dedicated Imaging Modalities
    Cieslewicz, Maja
    Andryszak, Natalia
    Pelka, Kacper
    Szczepanek-Parulska, Ewelina
    Ruchala, Marek
    Kunikowska, Jolanta
    Czepczynski, Rafal
    DIAGNOSTICS, 2024, 14 (15)
  • [27] A pilot study of 68 Ga-PSMA-617 PET/CT imaging and 177Lu-EB-PSMA-617 radioligand therapy in patients with adenoid cystic carcinoma
    Guochang Wang
    Mengjiao Zhou
    Jie Zang
    Yuanyuan Jiang
    Xiaohong Chen
    Zhaohui Zhu
    Xiaoyuan Chen
    EJNMMI Research, 12
  • [28] Imaging of Prostate Cancer Recurrence in the Vas Deferens With 68Ga-PSMA PET/CT
    Priftakis, Dimitrios
    Afaq, Asim
    Bomanji, Jamshed
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (01) : 49 - 51
  • [29] 68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
    de Keizer B.
    Krijger G.C.
    Ververs F.T.
    van Es R.J.J.
    de Bree R.
    Willems S.
    Nuclear Medicine and Molecular Imaging, 2017, 51 (4) : 360 - 361
  • [30] Bilateral Adrenal Metastasis of Prostatic Adenocarcinoma on 68Ga-PSMA PET/CT Imaging
    Beyhan, Ediz
    Bektas, Ceyda Turan
    Baloglu, Mehmet Can
    Tosunoglu, Zehranur
    Cermik, Tevfik Fikret
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (07) : e324 - e326
12345